Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare business, Opella, to private equity firm CD&R. The valuation of Opella is based on an enterprise value of 16 billion euros.
Sanofi will remain a significant shareholder, supporting Opella in its future growth and path to independence. Bpifrance is expected to participate as a minority shareholder with an approximate 2% stake.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.